tirzepatide surmount 1 once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial surmount-1 trial tirzepatide obesity without

Glutathione with Vitamin C & E A powerful antioxidant that is not only benefit the skin but also has a positive impact on the overall health

If a shipment arrives damaged or the seal is broken on arrival, contact us within 7 days and well replace or refund

Customized Labels We offer fully customized label design and printing services, allowing you to incorporate your own brand identity and product information with high precision and clarity

In head-to-head comparison during the STEP trials, semaglutide 2.4 mg weekly produced significantly greater weight reduction than liraglutide 3.0 mg daily, approximately 15% versus 7% of body weight over similar timeframes